---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-004905"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:23:41.858498+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Dermata Therapeutics dismisses Baker Tilly, appoints CBIZ CPAs as new auditor

## Summary
- Baker Tilly dismissed as independent auditor effective January 31, 2026.
- CBIZ CPAs (formerly Mayer Hoffman McCann) appointed February 2, 2026.
- No disagreements with Baker Tilly on accounting principles or disclosures.
- Baker Tilly's prior reports included a going-concern explanatory paragraph.
- CBIZ CPAs previously served as Dermata's auditor from 2016 to 2023.

## SEC filing metadata
- accession: 0001493152-26-004905
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/0001493152-26-004905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-004905
- JSON: https://secwatch.observer/filing/0001493152-26-004905.json
- Plain text: https://secwatch.observer/filing/0001493152-26-004905.txt

## Source-grounded claims
- claim_id: 03bc3d87233b8588c0cb5fb638733841dcca18e4
  claim: Dermata Therapeutics, Inc. dismissed Baker Tilly US, LLP as its auditor.
  evidence_excerpt: On January 30, 2026, Dermata Therapeutics, Inc. (the “Company”) notified Baker Tilly US, LLP (formerly Moss Adams LLP) (“Baker Tilly”) that Baker Tilly would be dismissed as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/0001493152-26-004905-index.htm
- claim_id: 504b42603dc1afe3b48b7a4623700ec3e81499bb
  claim: Dermata Therapeutics, Inc. engaged CBIZ CPAs P.C. as its auditor.
  evidence_excerpt: On February 2, 2026, the Audit Committee approved the appointment of CBIZ CPAs P.C., (formerly known as Mayer Hoffman McCann P.C.) (“CBIZ CPAs”) as the Company’s new independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/0001493152-26-004905-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.